Dosing errors may impact the risk of rt-PA for stroke: the multicenter rt-PA acute stroke survey
Authors:
- David TanneDTDavid Tanne
- Andrew M DemchukADAndrew M Demchuk
- Brett L CucchiaraBCBrett L Cucchiara
- Steven R LevineSLSteven R Levine
- Scott E KasnerSKScott E Kasner
- 1 January 2004
- journal article
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 13 (1) , 35-40
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Medication Errors in Acute Cardiac CareCirculation, 2002
- Comparison of errors in estimating weight and in dosing of single-bolus Tenecteplase with tissue plasminogen activator (TIMI 10B and ASSENT I)The American Journal of Cardiology, 2002
- Markers of Increased Risk of Intracerebral Hemorrhage After Intravenous Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke in Clinical PracticeCirculation, 2002
- Reducing medication errors: potential benefits of bolus thrombolytic agents.Academic Emergency Medicine, 2000
- Thrombolysis medication errors: benefits of bolus thrombolytic agentsThe American Journal of Cardiology, 2000
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Antithrombotic Therapy for Venous Thromboembolic DiseaseChest, 1995
- Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke.Stroke, 1994
- Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes.Stroke, 1992
- Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1986